{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T17:46:00Z","timestamp":1776447960956,"version":"3.51.2"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jtos.2022.09.001","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T12:32:44Z","timestamp":1663158764000},"page":"197-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Redefining ocular drug delivery"],"prefix":"10.1016","volume":"26","author":[{"given":"Allisa J.","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer S.","family":"Steger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1959-8770","authenticated-orcid":false,"given":"Alan L.","family":"Robin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtos.2022.09.001_bib1","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.ophtha.2015.03.026","article-title":"The most common barriers to glaucoma medication adherence: a cross-sectional survey","volume":"122","author":"Newman-Casey","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtos.2022.09.001_bib2","series-title":"Summaries of previous studies on micro-volume dosing of topical ophthalmics (table 1) and tear volume determination (table 2)","year":"2022"},{"key":"10.1016\/j.jtos.2022.09.001_bib3","first-page":"264","article-title":"Determination of tear volume and tear flow","volume":"5","author":"Mishima","year":"1966","journal-title":"Invest Ophthalmol"},{"key":"10.1016\/j.jtos.2022.09.001_bib4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1542-0124(12)70157-X","article-title":"Assessment of tear film dynamics: quantification approach","volume":"3","author":"Tomlinson","year":"2005","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2022.09.001_bib5","first-page":"709","article-title":"Simultaneous evaluation of tear turnover and corneal epithelial permeability by fluorophotometry in normal subjects and patients with keratoconjunctivitis sicca (KCS)","author":"Nelson","year":"1995","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.jtos.2022.09.001_bib6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jps.2600630304","article-title":"Drop size and initial dosing frequency problems of topically applied ophthalmic drugs","volume":"63","author":"Chrai","year":"1974","journal-title":"J Pharmaceut Sci"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012422000830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012422000830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:47:30Z","timestamp":1761540450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012422000830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":6,"alternative-id":["S1542012422000830"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2022.09.001","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redefining ocular drug delivery","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2022.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}